Clinical Trial Update: Etoposide in Treating Young Patients With Relapsed Ependymoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of etoposide for relapsed ependymoma in young patients. The current trial status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma

Drugs mentioned

• Etoposide (Etoposide)
• Toposar (Etoposide)
• VePesid (etoposide)

Snippet

Sponsor: Children's Cancer and Leukaemia Group | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: UNKNOWN